1,5-anhydroglucitol has been researched along with Chronic Kidney Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coresh, J; Grams, ME; Inker, LA; Köttgen, A; Levey, AS; Perrone, RD; Rebholz, CM; Sarnak, MJ; Shafi, T; Tin, A | 1 |
| Bai, Y; Song, Y; Wang, Y; Yang, R | 1 |
| Alexander, D; Boerwinkle, E; Coresh, J; Nettleton, JA; Yu, B; Zheng, Y | 1 |
| Coresh, J; Grams, M; Klein, R; Rawlings, AM; Selvin, E; Steffes, M | 1 |
| Lawler, PR; Mora, S | 1 |
| Hasslacher, C; Kulozik, F | 1 |
| Juraschek, SP; Selvin, E; Steffes, MW | 1 |
7 other study(ies) available for 1,5-anhydroglucitol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Metabolomic Alterations Associated with Cause of CKD.
Topics: Adult; Citrulline; Deoxyglucose; Female; Glomerulonephritis; Guanosine; Hippurates; Homovanillic Acid; Humans; Kynurenic Acid; Male; Metabolome; Middle Aged; Palmitic Acids; Polycystic Kidney Diseases; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic | 2017 |
Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
Topics: Adult; Aged; Biomarkers; Deoxyglucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Renal Insufficiency, Chronic; Uric Acid | 2019 |
Serum metabolomic profiling and incident CKD among African Americans.
Topics: Biomarkers; Black or African American; Chromatography, Liquid; Creatine; Cross-Sectional Studies; Deoxyglucose; Female; Gas Chromatography-Mass Spectrometry; Humans; Incidence; Indican; Kidney; Linear Models; Longitudinal Studies; Male; Metabolomics; Middle Aged; Proportional Hazards Models; Pyrrolidonecarboxylic Acid; Renal Insufficiency, Chronic; Risk Factors; Time Factors; United States | 2014 |
Association of 1,5-anhydroglucitol with diabetes and microvascular conditions.
Topics: Cohort Studies; Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Renal Insufficiency, Chronic; ROC Curve | 2014 |
Moving beyond mean glycemia: 1,5-anhydroglucitol and microvascular complications of diabetes.
Topics: Deoxyglucose; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Hyperglycemia; Male; Renal Insufficiency, Chronic | 2014 |
Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Topics: Aged; Albuminuria; Alpha-Globulins; Biomarkers; Creatinine; Deoxyglucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Male; Middle Aged; Regression Analysis; Renal Insufficiency, Chronic; Serum Albumin; Severity of Illness Index | 2016 |
Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
Topics: Age Factors; Aged; Biomarkers; Blood Glucose; Coronary Disease; Cross-Sectional Studies; Deoxyglucose; Fasting; Female; Fructosamine; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Glycosylation; Humans; Hyperglycemia; Hypertension; Male; Renal Insufficiency, Chronic; Serum Albumin; Sex Factors | 2012 |